ADCT
ADC Therapeutics SA
-0.03 (-2.38%)1.03USD592K成交股數–市值–本益比(近四季)–股價營收比+3.0%營收年增(近四季)2026-11-10下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。外國發行人(20-F)通常只申報半年或年度,逐季會有缺。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 18.6M+3% | 20.0M+15% | 30.1M+67% | 15.8M-8% | 18.1M+1% | 17.4M+5% | 18.0M+26% | 17.0M-11% | 17.8M | 16.6M | 14.3M | 19.2M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 17.4M | 19.9M | 18.2M | 26.8M | 30.1M | 28.9M | 32.5M | 24.3M | 25.7M | 30.3M | 27.1M | 31.3M |
| 銷售管理費用 | 9.7M | 9.9M | 9.5M | 8.3M | 8.8M | 10.0M | 10.0M | 10.2M | 12.0M | 11.3M | 9.6M | 12.0M |
| 營業利益 | −25.4M-42% | −25.2M-11% | −17.9M-50% | −31.0M+7% | −44.1M+31% | −28.5M-29% | −35.6M-2% | −29.0M-27% | −33.6M | −40.0M | −36.1M | −39.6M |
| 營業利益率 | -136.4% | -126.0% | -59.5% | -196.6% | -244.1% | -163.5% | -197.4% | -170.5% | -188.3% | -240.2% | -253.4% | -206.5% |
| 稅後淨利 | −16.6M-71% | −33.0M-15% | −6.4M-85% | −41.0M+12% | −56.6M+22% | −38.6M-55% | −44.0M-6% | −36.5M-25% | −46.6M | −85.1M | −46.7M | −48.9M |
| 淨利率 | -88.9% | -164.6% | -21.2% | -260.1% | -313.2% | -221.8% | -244.1% | -214.6% | -261.1% | -511.2% | -327.5% | -254.8% |
| 稀釋 EPS | -0.11-78% | -0.21-42% | 0.04-110% | -0.30-21% | -0.50-11% | -0.36-65% | -0.42-26% | -0.38-37% | -0.56 | -1.04 | -0.57 | -0.60 |
| 稀釋股數 | 155M | 154M | 127M | 136M | 114M | 107M | 105M | 95.7M | 82.6M | 81.7M | 82.3M | 81.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 219M | 231M | 261M | 235M | 265M | 195M | 274M | 300M | 234M | 279M | 310M | 348M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | 4.9M | 4.8M | 4.2M | 18.0M | 17.8M | 17.4M | 16.1M | 15.2M | 16.0M | 16.2M | – | – |
| 總資產 | 279M | 291M | 323M | 290M | 322M | 273M | 349M | 372M | 308M | 355M | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 508M | 508M | 509M | 528M | 521M | 511M | 521M | 503M | 502M | 503M | – | – |
| 股東權益 | −228M | −216M | −186M | −238M | −199M | −238M | −172M | −132M | −194M | −148M | −64.2M | −19.7M |
| 負債比 | 181.7% | 174.2% | 157.5% | 182.2% | 161.9% | 187.4% | 149.3% | 135.4% | 163.1% | 141.8% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −29.7M-47% | – | – | – | −56.3M | – | – | −44.1M | – | – | – |
| 資本支出 | – | 32K | – | – | – | 264K | – | – | 531K | – | – | – |
| 自由現金流 | – | −29.7M-47% | – | – | – | −56.6M | – | – | −44.6M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -148.5% | – | – | – | -325.2% | – | – | -250.0% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 81.4M
| Reportable | 81.4M | 100.0% | +14.9% |
|---|
地區2025 年度 · 81.4M
| 美國 | 73.6M | 90.4% | +6.2% |
|---|---|---|---|
| 歐洲中東非洲 | 7.8M | 9.6% | +401.3% |
產品／服務2025 年度 · 81.4M
| 產品 | 73.6M | 90.4% | +6.2% |
|---|---|---|---|
| License Revenues | 5.0M | 6.1% | – |
| Royalty Revenue | 2.8M | 3.4% | +80.2% |
| License And Royalty Revenue 小計 | 7.8M | 9.6% | +401.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 81.4M | +14.9% | −143M | -175.3% | -1.12 | −141M |
| FY2024 | 70.8M | +2.6% | −158M | -222.8% | -1.62 | −125M |
| FY2023 | 69.1M | -7.8% | −240M | -347.7% | -2.94 | −122M |
| FY2022 | 74.9M | – | −157M | -209.8% | -2.01 | −139M |